Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-(105017-38-7)
- Name: Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-
- Synonyms:
- Molecular Formula:C19H23NO3
- Molecular Weight:313.397
- CAS Registry Number:105017-38-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.105017-38-7 Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.105017-38-7 (R,R)-Reboxetine
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.105017-38-7 (R,R)-Reboxetine
Assay:> 95% Application:Adrenergic Uptake Inhibitors
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 105004-34-0/b-Alanine, N-[[1-hydroxy-4-[[4-[[[1-(4-hydroxyphenyl)-1H-tetrazol-5-yl]thio]methyl]-1- (4-nitrophenyl)-3-undecyl-1H-pyrazol-5-yl]oxy]-2-naphthalenyl]carbonyl]-
- 105004-54-4/2-(4-morpholinophenyl)ethanol
- 105005-07-0/3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl methyl ester
- 105005-18-3/3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl methyl ester
- 105008-12-6/Uranium, bis(diphenylmethanone)tetraiodo-
- 10500-86-4/Benzene, 1,2-bis[(2-methyl-2-propenyl)oxy]-
- 105010-30-8/4-Quinazolinamine, 6,7-dimethoxy-2-[4-(2-quinazolinyl)-1-piperazinyl]-, hydrochloride
- 105012-17-7/1,4-Diazoniabicyclo[2.2.2]octane, 1-decyl-4-dodecyl-, dibromide
- 105012-37-1/Borate(1-), tetraethynyl-, silver(1+)
- 105012-80-4/Isoquinoline, sulfate
- 105013-28-3/Benzenepropanoic acid, 2-chloro-5-fluoro-b-oxo-4-(4-pyridinyl)-, ethyl ester
- 105014-07-1/1,3-Dioxane, 2,2-diphenoxy-
- 105014-08-2/1,3-Dioxane, 5,5-dimethyl-2,2-diphenoxy-
- 105015-12-1/Hexagermin, hexafluorohexahydro-
- 105015-43-8/5(4H)-Oxazolone, 2,4-dimethyl-4-(phenylmethyl)-, (S)-
- 105015-53-0/2(3H)-Furanone, 5-butyldihydro-4-methyl-, (4R,5R)-
- 10501-56-1/4-Methylquinazoline 3-oxide
- 105017-08-1/1H-Pyrido[3,4-b]indol-7-ol, 2,3,4,9-tetrahydro-1-methyl-, (R)-
- 105017-31-0/L-Hydroxy Prolinol
- 105017-38-7/Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-
- 105018-54-0/L-Phenylalanine, N-(N-L-tyrosyl-L-phenylalanyl)-
- 105018-55-1/L-Tryptophan, N-[N-(N-L-tyrosyl-L-methionyl)glycyl]-
- 105018-58-4/Tin, dibutyldiiodo(tributylphosphine)-
- 105018-59-5/Tin, tributyliodo(tributylphosphine)-
- 105018-77-7/1,2,4-Benzenetriol, 5-methoxy-3-(8,11,14-pentadecatrienyl)-, (Z,Z)-
- 105018-92-6/Spiro[bicyclo[2.2.1]heptane-2,2'-[1,3]dioxolane], 1,3,3-trimethyl-
- 105018-96-0/1-Naphthalenecarboxylic acid, 3,4,4a,5,6,7,8,8a-octahydro-2,5,5,8a-tetramethyl-3-oxo-, methyl ester, trans-
- 105018-97-1/1,4-Dioxaspiro[4.5]decane, 7-methoxy-7-methyl-
- 105019-17-8/Propyl, 1-(ethoxycarbonyl)-
- 105019-19-0/Propyl, 1-(ethoxycarbonyl)-2,2-dimethyl-